1-3 of 3
Anthony R. Porcari, PhD PharmD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Time in Therapeutic Range (TTR) and Relative Efficacy and Safety of Treatment with Apixaban or Enoxaparin/Warfarin for Acute Symptomatic Venous Thromboembolism: An Analysis of the Amplify Trial Data

Alexander Cohen, MD, Alexander S. Gallus, MD, Giancarlo Agnelli, MD, Harry R Buller, MD PhD, Raphael Pak, PhD, Anthony R. Porcari, PhD PharmD, Gary E. Raskob, PhD, Jeffrey I. Weitz, MDFRCPC, Takaharu Yamabe, PhD
Journal: Blood
Blood (2014) 124 (21): 1543.
https://doi.org/10.1182/blood.V124.21.1543.1543
Published: 2014
Journal Articles

Apixaban Reduces Hospitalization In Patients With Venous Thromboembolism: An Analysis Of The AMPLIFY-EXT Trial

Xianchen Liu, MD, PhD, John Thompson, PhD, Hemant Phatak, PhD, Jack Mardekian, PhD, Anthony R. Porcari, PhD, PharmD, Margot R. Johnson, MD, BSC
Journal: Blood
Blood (2013) 122 (21): 3638.
https://doi.org/10.1182/blood.V122.21.3638.3638
Published: 2013
Journal Articles

Two Doses of Apixaban for the Extended Treatment of Venous Thromboembolism

Giancarlo Agnelli, MD, Harry Roger Buller, MD, PhD, Alexander Cohen, MD, Madelyn Curto, DVM, Alexander S. Gallus, M.D., Margot R. Johnson, MD, BSC, Anthony R. Porcari, PhD, PharmD, Gary E Raskob, PhD, Jeffrey I. Weitz, MD
Journal: Blood
Blood (2012) 120 (21): LBA-1.
https://doi.org/10.1182/blood.V120.21.LBA-1.LBA-1
Published: 2012